These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25618219)

  • 1. TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.
    Stone JD; Harris DT; Kranz DM
    Curr Opin Immunol; 2015 Apr; 33():16-22. PubMed ID: 25618219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer-specific mutations by T cell receptor gene therapy.
    Blankenstein T; Leisegang M; Uckert W; Schreiber H
    Curr Opin Immunol; 2015 Apr; 33():112-9. PubMed ID: 25728991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell Receptors for Clinical Therapy:
    Kunert A; Obenaus M; Lamers CHJ; Blankenstein T; Debets R
    Clin Cancer Res; 2017 Oct; 23(20):6012-6020. PubMed ID: 28645940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
    Raman MC; Rizkallah PJ; Simmons R; Donnellan Z; Dukes J; Bossi G; Le Provost GS; Todorov P; Baston E; Hickman E; Mahon T; Hassan N; Vuidepot A; Sami M; Cole DK; Jakobsen BK
    Sci Rep; 2016 Jan; 6():18851. PubMed ID: 26758806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.
    Simon P; Omokoko TA; Breitkreuz A; Hebich L; Kreiter S; Attig S; Konur A; Britten CM; Paret C; Dhaene K; Türeci Ö; Sahin U
    Cancer Immunol Res; 2014 Dec; 2(12):1230-44. PubMed ID: 25245536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A signal integration model of thymic selection and natural regulatory T cell commitment.
    Khailaie S; Robert PA; Toker A; Huehn J; Meyer-Hermann M
    J Immunol; 2014 Dec; 193(12):5983-96. PubMed ID: 25392533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
    Spear TT; Wang Y; Smith TW; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
    Mol Ther; 2018 Apr; 26(4):996-1007. PubMed ID: 29503203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.
    Bijen HM; van der Steen DM; Hagedoorn RS; Wouters AK; Wooldridge L; Falkenburg JHF; Heemskerk MHM
    Mol Ther; 2018 May; 26(5):1206-1214. PubMed ID: 29567312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines.
    Zhao Y; Bennett AD; Zheng Z; Wang QJ; Robbins PF; Yu LY; Li Y; Molloy PE; Dunn SM; Jakobsen BK; Rosenberg SA; Morgan RA
    J Immunol; 2007 Nov; 179(9):5845-54. PubMed ID: 17947658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antitumor Effects of Vaccine-Activated CD8
    Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y
    Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful Allies.
    Hammerl D; Rieder D; Martens JWM; Trajanoski Z; Debets R
    Trends Immunol; 2018 Nov; 39(11):921-936. PubMed ID: 30309702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR tuning of T cell subsets.
    Cho JH; Sprent J
    Immunol Rev; 2018 May; 283(1):129-137. PubMed ID: 29664578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy.
    Sharma P; Kranz DM
    Crit Rev Immunol; 2019; 39(2):105-122. PubMed ID: 31679251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly cross-reactive T cell responses to myelin basic protein epitopes reveal a nonpredictable form of TCR degeneracy.
    Loftus C; Huseby E; Gopaul P; Beeson C; Goverman J
    J Immunol; 1999 Jun; 162(11):6451-7. PubMed ID: 10352259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.